Understanding the Stakes: Sir John Bell’s Warning Sir John Bell, a prominent figure in the UK’s biotechnology sector, has raised significant concerns over the pharmaceutical industry’s future in the UK. His recent caution follows the announcement that US pharmaceutical giant Merck is scrapping its ambitious £1 billion research center planned for King’s Cross, London. This…